TYRA BIOSCIENCES INC (TYRA) Fundamental Analysis & Valuation

NASDAQ:TYRA • US90240B1061

Current stock price

39.24 USD
-0.37 (-0.93%)
Last:

This TYRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TYRA Profitability Analysis

1.1 Basic Checks

  • TYRA had negative earnings in the past year.
  • TYRA had a negative operating cash flow in the past year.
  • TYRA had negative earnings in each of the past 5 years.
  • TYRA had a negative operating cash flow in each of the past 5 years.
TYRA Yearly Net Income VS EBIT VS OCF VS FCFTYRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -42.44%, TYRA perfoms like the industry average, outperforming 53.58% of the companies in the same industry.
  • TYRA's Return On Equity of -46.28% is fine compared to the rest of the industry. TYRA outperforms 64.80% of its industry peers.
Industry RankSector Rank
ROA -42.44%
ROE -46.28%
ROIC N/A
ROA(3y)-32.28%
ROA(5y)-25.24%
ROE(3y)-35.11%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
TYRA Yearly ROA, ROE, ROICTYRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • TYRA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TYRA Yearly Profit, Operating, Gross MarginsTYRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. TYRA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, TYRA has more shares outstanding
  • The number of shares outstanding for TYRA has been increased compared to 5 years ago.
  • TYRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TYRA Yearly Shares OutstandingTYRA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
TYRA Yearly Total Debt VS Total AssetsTYRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 52.30 indicates that TYRA is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of TYRA (52.30) is better than 95.55% of its industry peers.
  • There is no outstanding debt for TYRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 52.3
ROIC/WACCN/A
WACCN/A
TYRA Yearly LT Debt VS Equity VS FCFTYRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • TYRA has a Current Ratio of 14.67. This indicates that TYRA is financially healthy and has no problem in meeting its short term obligations.
  • TYRA has a better Current ratio (14.67) than 91.49% of its industry peers.
  • A Quick Ratio of 14.67 indicates that TYRA has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 14.67, TYRA belongs to the top of the industry, outperforming 91.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.67
Quick Ratio 14.67
TYRA Yearly Current Assets VS Current LiabilitesTYRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TYRA Growth Analysis

3.1 Past

  • The earnings per share for TYRA have decreased strongly by -33.11% in the last year.
EPS 1Y (TTM)-33.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • TYRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.61% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-16.43%
EPS Next 2Y-10.62%
EPS Next 3Y12.97%
EPS Next 5Y20.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TYRA Yearly Revenue VS EstimatesTYRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TYRA Yearly EPS VS EstimatesTYRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

0

4. TYRA Valuation Analysis

4.1 Price/Earnings Ratio

  • TYRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TYRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TYRA Price Earnings VS Forward Price EarningsTYRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TYRA Per share dataTYRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • TYRA's earnings are expected to grow with 12.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.62%
EPS Next 3Y12.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TYRA Dividend Analysis

5.1 Amount

  • TYRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TYRA Fundamentals: All Metrics, Ratios and Statistics

TYRA BIOSCIENCES INC

NASDAQ:TYRA (4/6/2026, 1:04:18 PM)

39.24

-0.37 (-0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-02
Earnings (Next)04-30
Inst Owners108.74%
Inst Owner Change0%
Ins Owners2.95%
Ins Owner Change-3.96%
Market Cap2.11B
Revenue(TTM)N/A
Net Income(TTM)-119.95M
Analysts87.78
Price Target51 (29.97%)
Short Float %13.12%
Short Ratio6.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.17%
Min EPS beat(2)-5.8%
Max EPS beat(2)1.47%
EPS beat(4)3
Avg EPS beat(4)3.6%
Min EPS beat(4)-5.8%
Max EPS beat(4)12.85%
EPS beat(8)6
Avg EPS beat(8)9.2%
EPS beat(12)8
Avg EPS beat(12)5.49%
EPS beat(16)10
Avg EPS beat(16)1.33%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.17%
PT rev (3m)54.44%
EPS NQ rev (1m)-4.24%
EPS NQ rev (3m)-5.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.16
P/tB 8.16
EV/EBITDA N/A
EPS(TTM)-2.01
EYN/A
EPS(NY)-2.34
Fwd EYN/A
FCF(TTM)-1.77
FCFYN/A
OCF(TTM)-1.77
OCFYN/A
SpS0
BVpS4.81
TBVpS4.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.44%
ROE -46.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.28%
ROA(5y)-25.24%
ROE(3y)-35.11%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.82%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.67
Quick Ratio 14.67
Altman-Z 52.3
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)123.96%
Cap/Depr(5y)206%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.56%
EPS Next Y-16.43%
EPS Next 2Y-10.62%
EPS Next 3Y12.97%
EPS Next 5Y20.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-18.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.36%
OCF growth 3YN/A
OCF growth 5YN/A

TYRA BIOSCIENCES INC / TYRA Fundamental Analysis FAQ

What is the fundamental rating for TYRA stock?

ChartMill assigns a fundamental rating of 3 / 10 to TYRA.


Can you provide the valuation status for TYRA BIOSCIENCES INC?

ChartMill assigns a valuation rating of 0 / 10 to TYRA BIOSCIENCES INC (TYRA). This can be considered as Overvalued.


Can you provide the profitability details for TYRA BIOSCIENCES INC?

TYRA BIOSCIENCES INC (TYRA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for TYRA BIOSCIENCES INC?

The Earnings per Share (EPS) of TYRA BIOSCIENCES INC (TYRA) is expected to decline by -16.43% in the next year.